Related Experiment Video
Updated: Feb 5, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
Rituximab treatment for immune-complex-mediated membranoproliferative glomerulonephritis
Qianshuo Lu1, Li Zuo1, Bao Dong1
1Department of Nephrology, Peking University People's Hospital, Beijing,100044, China.
Abstract:
Immune-complex-mediated membranoproliferative glomerulonephritis (MPGN) is a new concept that refers to MPGN with immunoglobulin and C3 deposition in the kidney based on immunofluorescence examination. It is associated with pathological autoantibodies production. Rituximab, as an immunosuppressive agent, can eliminate B cells selectively. We reported a case that a patient with immune-complex-mediated MPGN and HCV infection, but no cryoglobulinemia, responded well to the treatment of low-dosage of rituximab and steroids. His proteinuria decreased remarkably with the serum creatinine and liver function remaining stable within 1 year. His favorable outcome suggests that low-dosage of rituximab in conjunction with steroids is an effective and safe treatment choice for immune-complex-mediated MPGN.
Related Concept Videos
Cell-mediated Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
What is the Immune System?
Humoral Immune Responses
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

